By Tom Kerr, CFA
NASDAQ: BENF
READ THE FULL BENF RESEARCH REPORT
1st Quarter 2027 Results (period ending June 30, 2026)
On August 14, 2026, Beneficient (NASDAQ: BENF) announced fiscal 1st quarter results for the period ending 6/30/26.
Beneficient reported $212.5 million of investments at fair value as of June 30, 2026, up from $195.5 million at the end of the prior fiscal year (3/31/26). These investments support a $186.0 million net loan portfolio, compared with $169.7 million previously, indicating continued growth in the company’s lending platform and underlying collateral base.
A major positive is the substantial reduction in operating expenses. 1st quarter operating expenses fell 84.3% to $12.5 million, although the current period included $1.8 million of interest related to a loss-contingency accrual. Excluding these unusual items, operating expenses declined 37.4% to $10.8 million, from $17.2 million a year earlier. This sharp reduction in the underlying cost structure could provide meaningful operating leverage as the company grows its loan portfolio and generates additional fee and interest income.
Beneficient is also continuing to monetize assets and expand its alternative-asset financing platform. Asset sales and equity redemptions from the Customer ExAlt Trusts generated $57.6 million of cumulative gross proceeds from inception through June 30, 2026, which have been used to reduce debt and fund working capital.
In addition, new primary capital transactions with two funds have added more than $16 million of alternative-asset interests to the collateral supporting the ExAlt loan portfolio. Importantly, because ExAlt Holdings is a direct subsidiary of Beneficient and is not structurally subordinated to BCH, earnings from these loans and related fees are expected to accrue directly to Beneficient’s common shareholders.
CEO James Silk stated, “Our first-quarter results for FY 2027 showed an extension in our operating strategy with the announcement of our first collateral management services engagement providing monitoring and reporting services on a portfolio of professionally managed alternative assets for a Texas state-chartered bank. Paired with over $16 million in new primary capital commitments, a streamlined cost structure, and an enhanced collateral base, we continue to strengthen our balance sheet and position the company for sustainable growth.”
As of June 30, 2026, the company had cash and cash equivalents of $5.6 million and total debt of $96.8 million. Distributions received from alternative assets and other securities held in custody totaled $1.9 million in the 1st quarter, compared to $3.7 million for the same period of fiscal 2026. Additionally, during the quarter, the company received proceeds of $5.0 million from the disposition of certain investments in alternative assets. Subsequent to June 30, 2026, the company issued two promissory notes totaling $4.0 million, resulting in proceeds of approximately $3.8 million, which have been used to provide working capital.
Valuation
Our adjusted DCF-derived calculation is approximately $9.00 per share. We also provide a simplified P/E multiple based on company segments. Based on our FY 2027 revenue and pre-tax income estimates, we arrive at a target price of $9.00 per share.
A material rebound in loan origination volumes (and therefore revenue and earnings power) likely remains dependent on further clarity on the company’s debt profile and capital structure post-resolution of litigation involving BENF’s former CEO. We continue to believe longer-term investors can capitalize on the current depressed stock price and realize sizeable returns over time, as the market increasingly appreciates BENF’s unique business model and outsized growth prospects.
Investment Thesis
Beneficient leverages a proprietary FinTech platform and an innovative/fiduciary trust structure branded as the ExAlt Plan to provide early exit liquidity solutions and custody/data analytics services to holders of alternative assets, including medium-to-high net worth (MHNW) individuals and small-to-mid-sized institutions (STMIs). In addition, the company delivers primary capital solutions to fundraising General Partners (GPs).
1. Unique business model, with sustainable competitive advantages
Beneficient provides liquidity to investors holding alternative assets through a trust-based structure, allowing customers to exchange these interests for cash, BENF stock, or both. Its Ben AltAccess® platform integrates liquidity, trust, custody, and analytics services, with financing overseen by a Kansas-regulated trust subsidiary.
2. Renewed Growth Expected
We expect origination volumes to reaccelerate as growing alternative AUM and muted distributions drive increasing demand for liquidity. Beneficient targets the underserved MHNW and STMI segments, where investors value price, cost, and timing certainty, with more than $2 trillion of U.S. assets and estimated annual liquidity demand exceeding $100 billion.
Beneficient is also expanding its addressable market through GP Solutions, the Preferred Liquidity Program, and Primary Capital Program, targeting funds with liquidity and fundraising needs. With more than $400 billion of potential new business across these programs, even modest win rates could drive meaningful transaction volumes and TBV/earnings growth.
3. Exposure to optimized alternative asset portfolio
Beneficient has built a diversified balance sheet primarily consisting of loans collateralized by alternative assets and direct investments across asset classes, sectors, and geographies. Continued portfolio growth should drive higher loan interest income while increasing Ben Liquidity deal flow, supporting revenue and operating income growth.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives payments totaling a maximum fee of up to $50,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.